The treatment and etiology of tics and Tourette syndrome.
D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002648:Child; D018492:Dopamine Antagonists; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010395:Penfluridol / Q000627:therapeutic use; D010640:Phenothiazines; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D013981:Tic Disorders / Q000188:drug therapy* / Q000209:etiology; D005879:Tourette Syndrome / Q000188:drug therapy* / Q000209:etiology
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D010640:Phenothiazines; D011619:Psychotropic Drugs; D010395:Penfluridol; D006220:Haloperidol